Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serum sodium and other extracellular electrolytes, including potassium, chloride, and bicarbonate, are vital inorganic ions that maintain the body's electrochemical gradients and fluid homeostasis (StatPearls, 2023). Sodium is the predominant extracellular cation and serves as the primary driver of extracellular fluid volume and osmotic pressure, while potassium is essential for maintaining the resting membrane potential necessary for nerve impulse transmission and cardiac rhythm (NIH, 2022). These electrolytes are not considered traditional therapeutic targets like receptors or enzymes; instead, they are physiological analytes regulated by a complex network of transporters (e.g., Na+/K+-ATPase, NKCC2), ion channels (e.g., ENaC), and endocrine signals such as aldosterone and vasopressin (Merck Manual, 2023). Drugs like diuretics, vaptans, and ion-exchange resins are used to manage electrolyte imbalances by altering their renal handling or gastrointestinal absorption. Precise regulation of these ions is clinically critical, as significant deviations can lead to severe complications such as life-threatening arrhythmias, seizures, or permanent neurological damage from rapid correction (PubMed, PMC6435000).
Pharmacological agents modulate electrolyte levels by targeting the proteins responsible for their transport and regulation. Diuretics inhibit specific renal transporters (e.g., NKCC2 in the Loop of Henle or NCC in the distal tubule) to increase the excretion of sodium and water (StatPearls, 2023). Vasopressin receptor antagonists (vaptans) block V2 receptors in the collecting duct to promote aquaresis without significant electrolyte loss, thereby raising serum sodium levels. Conversely, potassium binders like patiromer or sodium zirconium cyclosilicate act within the gastrointestinal lumen to exchange cations for potassium, facilitating its fecal excretion (PubMed, PMC5103604).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serum sodium and other extracellular electrolytes.